image
Henry Schein, Inc. HSIC
Healthcare - Medical - Distribution - NASDAQ - US
Watchlist
$ 71.98
1.2 %
$ 8.76 B
Market Cap
22.42
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one HSIC stock under the worst case scenario is HIDDEN Compared to the current market price of 72 USD, Henry Schein, Inc. is HIDDEN

HSIC Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one HSIC stock under the base case scenario is HIDDEN Compared to the current market price of 72 USD, Henry Schein, Inc. is HIDDEN

HSIC Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one HSIC stock under the best case scenario is HIDDEN Compared to the current market price of 72 USD, Henry Schein, Inc. is HIDDEN

HSIC Intrinsic Value
HIDDEN
SHOW
2. FUNDAMENTAL ANALYSIS

Price Chart HSIC

image
1M -2%
6M 3%
1Y 12%
3Y -6%
5Y 27%
All
$82.0$82.0$80.0$80.0$78.0$78.0$76.0$76.0$74.0$74.0$72.0$72.0$70.0$70.0$68.0$68.0$66.0$66.0$64.0$64.0$62.0$62.0Jan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '2515 Jun15 Jun
FINANCIALS
12.7 B REVENUE
2.71%
Growth Rates
1Year 2.71%
3Years 0.73%
5Years 4.88%
7Years 0.24%
10Years 2.02%
621 M OPERATING INCOME
0.98%
Growth Rates
1Year 0.98%
3Years -9.99%
5Years -2.87%
7Years -4.53%
10Years -1.40%
398 M NET INCOME
-4.33%
Growth Rates
1Year -4.33%
3Years -15.54%
5Years -11.16%
7Years -2.03%
10Years -2.36%
848 M OPERATING CASH FLOW
69.60%
Growth Rates
1Year 69.60%
3Years 6.12%
5Years 5.33%
7Years 6.50%
10Years 3.65%
-430 M INVESTING CASH FLOW
62.11%
Growth Rates
1Year 62.11%
3Years 14.05%
5Years -0.26%
7Years -3.31%
10Years 1.82%
-510 M FINANCING CASH FLOW
-72.75%
Growth Rates
1Year -72.75%
3Years -15.27%
5Years -18.75%
7Years -24.09%
10Years -12.67%
3.17 B REVENUE
-0.72%
Growth Rates
1Year 2.71%
3Years 0.73%
5Years 4.88%
7Years 0.24%
10Years 2.02%
175 M OPERATING INCOME
12.90%
Growth Rates
1Year 0.98%
3Years -9.99%
5Years -2.87%
7Years -4.53%
10Years -1.40%
113 M NET INCOME
17.71%
Growth Rates
1Year -4.33%
3Years -15.54%
5Years -11.16%
7Years -2.03%
10Years -2.36%
37 M OPERATING CASH FLOW
-81.86%
Growth Rates
1Year 69.60%
3Years 6.12%
5Years 5.33%
7Years 6.50%
10Years 3.65%
-99 M INVESTING CASH FLOW
-70.69%
Growth Rates
1Year 62.11%
3Years 14.05%
5Years -0.26%
7Years -3.31%
10Years 1.82%
89 M FINANCING CASH FLOW
143.63%
Growth Rates
1Year -72.75%
3Years -15.27%
5Years -18.75%
7Years -24.09%
10Years -12.67%
Balance Sheet Henry Schein, Inc.
image
Current Assets 3.98 B
Cash & Short-Term Investments 122 M
Receivables 1.48 B
Other Current Assets 2.38 B
Non-Current Assets 6.24 B
Long-Term Investments 170 M
PP&E 824 M
Other Non-Current Assets 5.24 B
14.50 %23.28 %8.06 %51.29 %Total Assets$10.2b
Current Liabilities 2.8 B
Accounts Payable 962 M
Short-Term Debt 781 M
Other Current Liabilities 1.06 B
Non-Current Liabilities 2.58 B
Long-Term Debt 2.09 B
Other Non-Current Liabilities 492 M
17.88 %14.51 %19.70 %38.77 %9.14 %Total Liabilities$5.4b
EFFICIENCY
Earnings Waterfall Henry Schein, Inc.
image
Revenue 12.7 B
Cost Of Revenue 8.66 B
Gross Profit 4.02 B
Operating Expenses 3.4 B
Operating Income 621 M
Other Expenses 223 M
Net Income 398 M
14b14b12b12b10b10b8b8b6b6b4b4b2b2b0013b(9b)4b(3b)621m(223m)398mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
31.69% GROSS MARGIN
31.69%
Averages
1Year 31.69%
3Years 31.09%
5Years 30.14%
7Years 29.84%
10Years 29.24%
4.90% OPERATING MARGIN
4.90%
Averages
1Year 4.90%
3Years 5.26%
5Years 5.59%
7Years 5.84%
10Years 6.13%
3.08% NET MARGIN
3.08%
Averages
1Year 3.08%
3Years 3.57%
5Years 3.96%
7Years 4.15%
10Years 4.12%
11.49% ROE
11.49%
Averages
1Year 11.49%
3Years 12.83%
5Years 13.79%
7Years 14.92%
10Years 15.36%
3.82% ROA
3.82%
Averages
1Year 3.82%
3Years 4.67%
5Years 5.33%
7Years 5.75%
10Years 6.03%
5.69% ROIC
5.69%
Averages
1Year 5.69%
3Years 6.70%
5Years 7.59%
7Years 8.24%
10Years 8.81%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Henry Schein, Inc.
image
700m700m600m600m500m500m400m400m300m300m200m200m100m100m0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 398 M
Depreciation & Amortization 268 M
Capital Expenditures -187 M
Stock-Based Compensation 39 M
Change in Working Capital 140 M
Others -57 M
Free Cash Flow 661 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Henry Schein, Inc.
image
Wall Street analysts predict an average 1-year price target for HSIC of $79.8 , with forecasts ranging from a low of $67 to a high of $92 .
HSIC Lowest Price Target Wall Street Target
67 USD -6.92%
HSIC Average Price Target Wall Street Target
79.8 USD 10.79%
HSIC Highest Price Target Wall Street Target
92 USD 27.81%
Price
Max Price Target
Min Price Target
Average Price Target
95959090858580807575707065656060Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 5
6. Ownership
Insider Ownership Henry Schein, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
672 K USD 3
6-9 MONTHS
918 K USD 1
9-12 MONTHS
1.67 M USD 2
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Here's Why Henry Schein (HSIC) is a Strong Value Stock The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. zacks.com - 2 weeks ago
Here's Why Henry Schein (HSIC) is a Strong Growth Stock Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. zacks.com - 2 weeks ago
Henry Schein (HSIC) Up 6.5% Since Last Earnings Report: Can It Continue? Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? zacks.com - 3 weeks ago
Updated: Henry Schein to Participate in Upcoming Investor Conference in June MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conference in June: Jefferies Global Healthcare Conference at the Marriott Marquis hotel, New York City, on June 4, at 12:50 p.m. Eastern time. Henry Schein's presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcasts. Replays will be availab. businesswire.com - 3 weeks ago
Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. zacks.com - 1 month ago
Should You Retain Henry Schein Stock in Your Portfolio Right Now? Investors are optimistic about HSIC, owing to the strong performance of its Henry Schein One business. zacks.com - 1 month ago
Henry Schein One Unveils The Catalyst Index, a Look into Dentistry's Top 10% AMERICAN FORK, Utah--(BUSINESS WIRE)--Henry Schein One today announced the launch of The 2025 Catalyst Index, its exclusive report offering dental practices an unparalleled view into the strategies transforming performance across the industry. Built on years of trusted benchmarking and informed by Henry Schein One's most connected platform, the fourth annual report, The Catalyst Index, raises the bar by revealing the specific actions that distinguish the top 10% of DSOs and private practices. “. businesswire.com - 1 month ago
Henry Schein Post Earnings Review HSIC's Q1 earnings were solid, with full-year EPS guidance of $4.80-$4.94 and analysts expecting $5.27 in 2026. New business units and revamped sales incentives aim to reignite revenue growth after stagnation since 2022; management is optimistic about their impact. Ongoing share buybacks (32% reduction in shares since 2011) continue to support EPS and provide downside support for the stock. seekingalpha.com - 1 month ago
Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced the successful completion of a $250 million strategic investment by funds affiliated with KKR, a leading global investment firm. Upon the closing of this transaction, KKR has become the holder of approximately 12% of the common shares of Henry Schein. In connection with the investment, William K. “Dan” Daniel,. businesswire.com - 1 month ago
Henry Schein to Participate in Upcoming Investor Conference in June MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conference in June: Jefferies Global Healthcare Conference at the Marriott Marquis hotel, New York City, on June 4, 2025, at 1:20 p.m. Eastern time. Henry Schein's presentations can be heard via live webcast by visiting https://investor.henryschein.com/webcasts. Replays. businesswire.com - 1 month ago
These Analysts Lower Their Forecasts On Henry Schein Following Q1 Results Henry Schein Inc. HSIC reported mixed results for its first-quarter on Monday. benzinga.com - 1 month ago
Henry Schein to Participate in Upcoming Investor Conferences in May MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in May: Bank of America Healthcare Conference at the Encore Hotel in Las Vegas on May 14, 2025, at 10:00 a.m. Pacific time (1:00 p.m. Eastern time). Stifel Jaws & Paws Conference at Lotte Hotel, New York City, on May 29, 2025, at 12:40 p.m. Eastern time. businesswire.com - 1 month ago
8. Profile Summary

Henry Schein, Inc. HSIC

image
COUNTRY US
INDUSTRY Medical - Distribution
MARKET CAP $ 8.76 B
Dividend Yield 0.00%
Description Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Contact 135 Duryea Road, Melville, NY, 11747 https://www.henryschein.com
IPO Date Nov. 3, 1995
Employees 25000
Officers Mr. Mark E. Mlotek Executive Vice President, Chief Strategic Officer & Executive Director Mr. Stanley M. Bergman CPA Executive Chairman & Chief Executive Officer Mr. Walter Siegel Senior Vice President & Chief Legal Officer Mr. Mark Hillebrandt Vice President & Chief Data Revenue Officer Ms. Olga Timoshkina Vice President of Corporate Finance, Chief Accounting Officer & Corporate Controller Mr. Christopher Pendergast Senior Vice President & Chief Technology Officer Mr. Graham Stanley Vice President of Investor Relations & Strategic Finance Project Officer Ms. Christine Sheehy Senior Vice President & Chief Human Resources Officer Mr. Ronald N. South Senior Vice President & Chief Financial Officer Mr. Michael Saul Ettinger Executive Vice President & Chief Operating Officer